Multi-super specialty care · Bhubaneswar

Dr. Avinash Badajena

Dr. Avinash Badajena

MBBS, MD
Associate Consultant

OPD Days & Timings

Monday to Saturday, 9:30 AM – 5:30 PM (Except Public Holidays)

Doctor Experience

Dr Avinash Badajena is a Junior Consultant in Radiation Oncology department, SUM Ultimate Medicare. He completed his MD in the field of radiation oncology from King George’s medical university Lucknow and is a dedicated professional in the management of cancer patients. After completing his post-graduate training he continued there as senior Resident in Department of Radiotherapy for one year. After that he joined as a Senior Resident in department of Radiotherapy, AIIMS Bhubaneswar for a period of two years. He is engaged as a radiation oncologist in Sum Ultimate since-then. Along with oncological patient management, he is actively engaged in research and academic activities throughout this period, including various publications in reputed indexed international national journals.

Expertise

  • High Precision Radiotherapy
  • Adaptive Radiotherapy
  • Sterotactic Radiosurgery (SRS)
  • Stereotactic Radiotherapy (SRT)
  • Stereotactic Body radiotherapy (SBRT)
  • Intensity Modulated Radiotherapy
  • Volumetric Modulated Arc Therapy
  • 3D Conformal Radiotherapy
  • Image Guided Brachytherapy in Gynecological, Esophageal, Head and Neck and Endobronchial Malignancies
  • Interstitial Brachytherapy
  • Surface Mould Brachytherapy

Paper Presentation

Avinash A, Badajena A, Panda SK, et al. Multimodal management of primary intestinal type endocervical adenocarcinoma of cervix: a rare case report. Therp Radiol Oncol. 2025;9:17

Mukherjee P, Barik SK, Majumdar SKD, Das DK, Ramasubbu MK, Ahmed SS, Muduly DK, Sasmal PK, Mishra TS, Pattnaik B, Dutta T, Gupta S, Dhar SS, Pattanaik A, Mahapatra BR, Badajena A, et al. Assessment of response to total neoadjuvant therapy in carcinoma rectum: A real-world prospective observational study from eastern India. J Cancer Res Ther. 2025;21(5):1038-1045.

Barik SK, Muraleedharan A, Badajena A, et al. Radiotherapy for refractory eumycetoma: another weapon in the antifingal armoury? J Radioth Pract. 2024;23:e30

Mahapatra BR, Barik SK, Das DK, Badajena A etal. Factors affecting the dosimetry of high-dose rate intracavitary brachytherapy in cervical cancer. J Radioth Pract. 2024;23:e9

Mahapatra B, Muraleedharan A, Badajena A, et al. Cutaneous Metastasis in a Treated Case of Cervical Cancer With Extraordinary Response to Chemotherapy: A Case Report of a Rare Event and Review of the Literature. Cureus 2023;15(2): e35083.

Muraleedharan, A., Barik, S.K., Das, D.K. Badajena A. et al. A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing. J Egypt Natl Canc Inst 2024;36;11.

Badajena A, Raturi VP, Srivastava K, Hojo H, Ohyoshi H, Bei Y et al. Prospective evaluation of the setup errors and its impact on safety margin for cervical cancer pelvic conformal radiotherapy. Repo of Pract Oncol Radioth. 2020;25:260-265

Raturi V, Hojo H, Bhatt MLB, Suhel M, Wu CT, Bei Y, Nakamura M, Okumura M, Zhang H, Parmar D, Badajena A, et al. Prospective evaluation of XRCC-1 Arg194Trp polymorphism as bio-predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation. Head Neck. 2020;42:1045-1056.

Raturi VP, Wu CT, Mohammad S, Hojo H, Bei Y, Nakamura M, Okumura M, Rachi T, Singh R, Gupta R, Parmar D, Hasan F, Gaur J, Kishan D, Kumar S, Badajena A, et al. Could excision repair cross-complementing group-1 mRNA expression from peripheral blood lymphocytes predict locoregional failure with cisplatin chemoradiation for locally advanced laryngeal cancer? Asia Pac J Clin Oncol. 2020 Apr;16(2):e19-e26.

Mahapatra BR, Barik BK, Muraleedharan A, Badajena A, Amritt A, Kanungo S, et al. High-Dose-Rate Intracavitary Brachytherapy Under Conscious Sedation a Viable Practical Alternative to Spinal Anaesthesia in Carcinoma Cervix: A Retrospective Study in a Tertiary Care Centre in Eastern India. Cureus. 2021 Nov 30;13(11):e20063.

Das Majumdar SK, Das DK, Barik S, Badajena A, Parida DK. Evaluation of Clinicopathological and Prognostic Factors of Male Breast Cancer: A Single-Centre Experience. Cureus. 2021;13(12):e20298.